Allspring Global Investments Holdings LLC Sells 7,535 Shares of SPDR S&P Biotech ETF $XBI

Allspring Global Investments Holdings LLC lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 134,066 shares of the exchange traded fund’s stock after selling 7,535 shares during the period. Allspring Global Investments Holdings LLC owned 0.25% of SPDR S&P Biotech ETF worth $11,118,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Goldman Sachs Group Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 33.0% in the first quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after acquiring an additional 3,353,029 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of SPDR S&P Biotech ETF by 625.1% in the first quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after acquiring an additional 12,344,558 shares during the period. Bessemer Group Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 4.0% in the first quarter. Bessemer Group Inc. now owns 1,432,066 shares of the exchange traded fund’s stock worth $116,141,000 after acquiring an additional 55,232 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of SPDR S&P Biotech ETF in the first quarter worth about $85,155,000. Finally, Hsbc Holdings PLC boosted its stake in shares of SPDR S&P Biotech ETF by 2.7% in the first quarter. Hsbc Holdings PLC now owns 819,267 shares of the exchange traded fund’s stock worth $65,379,000 after acquiring an additional 21,804 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.1%

NYSEARCA XBI opened at $107.80 on Friday. The firm has a market cap of $6.70 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The business has a 50-day moving average price of $96.06 and a 200-day moving average price of $86.64. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $110.96.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.